Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer.

Park HS, Yeo HY, Chang HJ, Kim KH, Park JW, Kim BC, Baek JY, Kim SY, Kim DY.

Yonsei Med J. 2013 Nov;54(6):1362-9. doi: 10.3349/ymj.2013.54.6.1362.

2.

Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.

Larrinaga G, Perez I, Sanz B, Beitia M, Errarte P, Fernández A, Blanco L, Etxezarraga MC, Gil J, López JI.

PLoS One. 2015 Mar 19;10(3):e0119436. doi: 10.1371/journal.pone.0119436.

3.

p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.

Yuan XS, Zhang Y, Guan XY, Dong B, Zhao M, Mao LL, Lu YY, Tian XY, Hao CY.

J Cancer Res Clin Oncol. 2013 Jul;139(7):1211-20. doi: 10.1007/s00432-013-1434-0.

PMID:
23576022
4.

Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.

Zhou T, Zhang G, Liu Z, Xia S, Tian H.

Int J Colorectal Dis. 2013 Jan;28(1):19-24. doi: 10.1007/s00384-012-1528-1.

PMID:
22772712
5.

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Shi H, Zhou Y, Liu H, Chen C, Li S, Li N, Li X, Zhang X, Zhang H, Wang W, Zhao Q.

BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.

6.

MTSS1 overexpression correlates with poor prognosis in colorectal cancer.

Wang D, Xu MR, Wang T, Li T, Zhu Jw.

J Gastrointest Surg. 2011 Jul;15(7):1205-12. doi: 10.1007/s11605-011-1546-2.

PMID:
21562916
7.

Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.

Oh SY, Kim YB, Suh KW, Paek OJ, Moon HY.

J Surg Res. 2012 Jan;172(1):102-8. doi: 10.1016/j.jss.2010.07.015.

PMID:
20851411
8.

L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.

Boo YJ, Park JM, Kim J, Chae YS, Min BW, Um JW, Moon HY.

Ann Surg Oncol. 2007 May;14(5):1703-11.

PMID:
17211730
9.

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.

Lin L, Piao J, Gao W, Piao Y, Jin G, Ma Y, Li J, Lin Z.

BMC Cancer. 2013 Jul 31;13:366. doi: 10.1186/1471-2407-13-366.

10.

Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.

Paik SS, Jang KS, Song YS, Jang SH, Min KW, Han HX, Na W, Lee KH, Choi D, Jang SJ.

Ann Surg Oncol. 2007 Dec;14(12):3453-9.

PMID:
17882496
11.

Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.

Gao XH, Liu QZ, Chang W, Xu XD, Du Y, Han Y, Liu Y, Yu ZQ, Zuo ZG, Xing JJ, Cao G, Fu CG.

Cancer. 2013 Jun 15;119(12):2212-22. doi: 10.1002/cncr.28052.

12.

Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.

Paik SS, Jang SM, Jang KS, Lee KH, Choi D, Jang SJ.

Ann Surg Oncol. 2009 Feb;16(2):297-303. doi: 10.1245/s10434-008-0221-7.

PMID:
19050975
13.

DPP10 modulates Kv4-mediated A-type potassium channels.

Zagha E, Ozaita A, Chang SY, Nadal MS, Lin U, Saganich MJ, McCormack T, Akinsanya KO, Qi SY, Rudy B.

J Biol Chem. 2005 May 13;280(19):18853-61.

14.

Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.

Petraki C, Dubinski W, Scorilas A, Saleh C, Pasic MD, Komborozos V, Khalil B, Gabril MY, Streutker C, Diamandis EP, Yousef GM.

Pathol Res Pract. 2012 Feb 15;208(2):104-8. doi: 10.1016/j.prp.2011.12.010.

PMID:
22285222
15.

Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.

Feng B, Xu WB, Zheng MH, Ma JJ, Cai Q, Zhang Y, Ji J, Lu AG, Qu Y, Li JW, Wang ML, Hu WG, Liu BY, Zhu ZG.

J Gastroenterol Hepatol. 2006 Oct;21(10):1596-603.

PMID:
16928223
16.

[Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].

Zhang MZ, Qiao YH, Suo ZH.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):848-52. Chinese.

PMID:
19173831
17.

Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.

Krajewska M, Kim H, Kim C, Kang H, Welsh K, Matsuzawa S, Tsukamoto M, Thomas RG, Assa-Munt N, Piao Z, Suzuki K, Perucho M, Krajewski S, Reed JC.

Clin Cancer Res. 2005 Aug 1;11(15):5451-61.

18.

Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.

Tachezy M, Zander H, Gebauer F, Marx A, Kaifi JT, Izbicki JR, Bockhorn M.

J Surg Res. 2012 Sep;177(1):e15-20. doi: 10.1016/j.jss.2012.02.013.

PMID:
22482754
19.

Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.

Martins SF, Garcia EA, Luz MA, Pardal F, Rodrigues M, Filho AL.

Cancer Genomics Proteomics. 2013 Mar-Apr;10(2):55-67.

PMID:
23603341
20.

Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.

Talieri M, Mathioudaki K, Prezas P, Alexopoulou DK, Diamandis EP, Xynopoulos D, Ardavanis A, Arnogiannaki N, Scorilas A.

Thromb Haemost. 2009 Apr;101(4):741-7.

PMID:
19350120

Supplemental Content

Support Center